Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
August 19, 2019
'Cautiously optimistic about HIV vaccines'
A conversation in advance of World AIDS Day with pioneering HIV researcher Dr. Larry Corey
The pride of Fred Hutch
HIV Vaccine Trials Network veteran Steven Wakefield named a grand marshal in Seattle Pride Parade
Meet Peru's HIV superhero
By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic
New HIV vaccine study launched for World AIDS Day
As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic
Insights from infants could inform HIV vaccine design
Dr. Julie Overbaugh mines decades-old samples to find new clues to effective immune responses to HIV
Enlisting the microbiome in the quest for an AIDS vaccine
We now know that microbial communities, especially in our guts, profoundly affect immune response
Will the flu vaccine work for you? Answer may be in your genes
Set of 9 genes that predicts flu response in adults under 35 could be first step to personalized vaccine
Community-building leads to record enrollment in HIV prevention study
Fighting the stigma of HIV among communities of color takes trust — and time
Training tomorrow's HIV researchers
With no end yet to the pandemic, a program supports young South African physician-scientists
Empowering ‘millions of women’ against HIV
AMP study in sub-Saharan Africa tests an antibody infusion that could put protection in women’s hands
Gut microbiome may have interfered with experimental HIV vaccines
Inoculating infants instead of adults could bypass problem, researchers say
How babies may help researchers build a better HIV vaccine
Data from a study done 20 years ago on maternal-infant HIV transmission give clues that could lead to better HIV vaccine design
Glenda Gray appointed new president of South African Medical Research Council - Fred Hutchinson Cancer Research Center
Fred Hutch HIV expert is first woman to lead nation’s premier medical-research organization
HIV Vaccine Trials Network among five nationwide selected to receive seven-year award - Fred Hutchinson Cancer Research Center
NIH funding will propel large-scale HIV vaccine clinical trials in South Africa and beyond
'Greatest burden': Why one doctor battles South Africa's HIV epidemic
In quest to find vaccine, attracting and retaining talented researchers is tougher than ever
Creating a future without HIV
South African government partners with the Hutch’s HIV Vaccine Trials Network to find an effective HIV vaccine
'I'm passionate about helping': Up close with an HIV vaccine trial participant
One South African woman explains why she volunteered for a vaccine being tested by HVTN
'Never give up': Researchers' tireless quest for HIV vaccines leads to Cape Town
HIV Vaccine Trials Network opens South African lab as it gears up to launch
HVTU, SCCA partner for Langston Hughes film festival April 16
Fred Hutchinson Cancer Research Center’s HIV Vaccine Trials Unit and Seattle Cancer Care Alliance will present an evening of three short films and discussion on the impact of HIV/AIDS in the Black community
President Corey elected to AAAS membership
Center president and director joins ranks of nation's most esteemed thinkers and doers with election to American Academy of Art and Sciences' 2012 class of fellows
Thai HIV vaccine trial follow-up studies offer possible explanation for HIV prevention success
Peter Gilbert and SCHARP researchers, HVTN Laboratory Program, part of worldwide effort to understand trial outcome, influence future HIV vaccine studies
Latest HVTNews now available online
Newsletter highlights clinical trial research, protocols in the field and the network's mission to drive the development of a safe, globally effective vaccine to prevent HIV
HIV Vaccine Trials Network relaunches publication
Newsletter highlights clinical trial research, protocols in the field and the network's mission to drive the development of a safe, globally effective vaccine to prevent HIV
McElrath receives HIV advocacy award
Julie McElrath honored as national recipient of Global Alliance to Immunize against AIDS achievement award